Cantel Medical Corporation
CMD
CMD was delisted on the 1st of June, 2021.
210 hedge funds and large institutions have $1.86B invested in Cantel Medical Corporation in 2020 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 67 increasing their positions, 76 reducing their positions, and 46 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
34% more call options, than puts
Call options by funds: $4.16M | Put options by funds: $3.1M
25% more capital invested
Capital invested by funds: $1.49B → $1.86B (+$373M)
4% less first-time investments, than exits
New positions opened: 44 | Existing positions closed: 46
1% less funds holding
Funds holding: 213 → 210 (-3)
12% less repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 76
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LGP
Leonard Green & Partners
Los Angeles,
California
|
+$74.6M |
| 2 |
BlackRock
New York
|
+$42.8M |
| 3 |
FAM
Fred Alger Management
New York
|
+$30.4M |
| 4 |
Goldman Sachs
New York
|
+$17.4M |
| 5 |
State Street
Boston,
Massachusetts
|
+$13.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Neuberger Berman Group
New York
|
-$64.9M |
| 2 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$51.7M |
| 3 |
Millennium Management
New York
|
-$20.9M |
| 4 |
CCM
Copeland Capital Management
Conshohocken,
Pennsylvania
|
-$17.7M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$14.8M |
CMD Hedge Fund Activity: Q2 2020 in Review
210 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical Corporation (CMD) for Q2 2020, worth a combined $1.86B — up 25% from $1.49B a quarter earlier.
Sellers outnumbered buyers: 46 funds closed out of CMD and 44 opened new positions — a net loss of 2 holders — while 76 trimmed existing stakes and 67 added.
The largest buyer was Leonard Green & Partners, opening a new position worth an estimated $74.6M. The largest seller was Neuberger Berman Group, exiting entirely with an estimated $64.9M sold.
- 210 institutional investors held Cantel Medical Corporation (CMD) as of Q2 2020, down from 213 in Q1 2020.
- Funds reported $1.86B of Cantel Medical Corporation stock for Q2 2020, up 25% quarter-over-quarter.
- 44 funds opened new Cantel Medical Corporation positions in Q2 2020 and 46 closed out, a net change of -2 holders.
- The largest Cantel Medical Corporation buyer in Q2 2020 was Leonard Green & Partners, an estimated $74.6M added.
- The largest Cantel Medical Corporation seller in Q2 2020 was Neuberger Berman Group, an estimated $64.9M sold.
Based on aggregated 13F filings for Q2 2020.